CRISPR Therapeutics AG - Common Shares (CRSP)
43.34
-2.19 (-4.81%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 45.53 |
|---|---|
| Open | 44.67 |
| Bid | 42.60 |
| Ask | 43.33 |
| Day's Range | 42.78 - 46.07 |
| 52 Week Range | 36.52 - 79.33 |
| Volume | 2,929,741 |
| Market Cap | 3.42B |
| PE Ratio (TTM) | -9.963 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,687,770 |
